Page 51 - Terminology-Clinical-Research
P. 51

submission is successful the regulatory authorities will   Reporting (or comparison) group: A grouping of
        grant marketing authorization (permission to sell the drug).   participants in a clinical study that is used in summarizing
        Examples of regulatory authorities include The Food and   the data collected during the study. This grouping may be
        Drug Administration (FDA) in the U.S. and the European   the same as or different from a study arm.
        Medicines Agency (EMA) in Europe. Note: In the ICH
        GCP guideline the term includes the authorities that review   Representative: See Legally acceptable representative.
        submitted clinical data and those that conduct inspections.   Rescue medication: A quick-relief or fast-acting
        These bodies are sometimes referred to as competent
        authorities.                                           medication patients in clinical trials may be given besides
                                                               the investigational drug or control that can alleviate
        Relative survival rate: Ratio of a cancer patient’s chance   symptoms due to disease or lack of efficacy of the study
        of surviving a given time interval compared with that of an   treatment. It acts quickly to stop symptoms, but the effects
        average person without cancer of the same age and sex.  are not long lasting.
        Release time allowance: When included in a funding     Research (biomedical): Research with the goal of
        opportunity description, is an eligible expense to facilitate   understanding normal and abnormal human functioning,
        the participation of knowledge users in a research program.   at the molecular, cellular, organ system and whole body
        Funds are used to compensate the organization of the   levels, including development of tools and techniques
        knowledge user for his/her time spent engaged in the   to be applied for this purpose; developing new therapies
        research program. Release time allowance requests will   or devices that improve health or the quality of life of
        not be considered for the following: 1. individuals with   individuals, up to the point where they are tested on human
        salaried academic research appointments; 2. the cost of   subjects. Studies on human subjects that do not have a
        teaching time to allow the individual to engage in research;   diagnostic or therapeutic orientation.
        3. supplementing or replacing part of the salary of a   Research (clinical): Research with the goal of improving
        researcher on sabbatical from their main appointment.
                                                               the diagnosis, and treatment (including rehabilitation and
        Reliability, psychometric: The degree to which a       palliation), of disease and injury; and improving the health
        psychometric “instrument” is free from random error either   and quality of life of individuals as they pass through
        by testing the homogeneity of content on multi-item tests   normal life stages. Research on, or for the treatment of,
        with internal consistency evaluation or testing the degree to   patients. A CIHR theme.
        which the instrument yields stable scores over time. Note:
        Reliability pertains to questions concerning whether an   Research (health services): Research with the goal
        instrument is accurate, repeatable, and sensitive. Reliability   of improving the efficiency and effectiveness of health
                                                               professionals and the health care system, through changes
        is distinguished from validation, which answers whether   to practice and policy. Health services research is a
        the instrument (e.g., questionnaire) actually measure   multidisciplinary field of scientific investigation that studies
        the selected “construct” (latent variable). For example a
        balance (scale) is easily understood as a possibly valid   how social factors, financing systems, organizational
        instrument to measure body weight. Its reliability would   structures and processes, health technologies, and personal
                                                               behaviours affect access to health care, the quality and cost
        be assessed by measuring the sensitivity, repeatability   of health care, and, ultimately, Canadians’ health and well-
        and accuracy of the balance. The validity of using the   being. A CIHR theme.
        balance for a particular purpose could then be established
        by comparing the measured reliability to the reliability   Research administration: Institution officials who provide
        required for that purpose.                             administrative services to researchers, from offices such
                                                               as the research grants office, research accounting office or
        Removed location countries: Countries that appeared    scholarships liaison office, as relevant.
        under Listed Location Countries but were removed from
        the study record by the data provider.                 Research associate: A researcher who: 1. has completed
                                                               formal training in research in a discipline relevant to health
        Repeat rule: Guide for repeating activities specified in
        protocol, including such features as the number of cycles   research, usually a Masters or PhD; 2. is employed by an
                                                               institution; 3. works under the supervision of a Principal
        and the criteria for stopping.
                                                               Applicant, i.e., they are not independent researchers; 4.
        Replacement: The act of enrolling a clinical trial subject to   may contribute substantially to the intellectual content of
        compensate for the withdrawal of another.              the research; 5. may contribute to, but is not ultimately


                                             TERMINOLOGY CLINICAL RESEARCH                                        51
   46   47   48   49   50   51   52   53   54   55   56